A Study of LY3462817 in Participants With Rheumatoid Arthritis

Clinical trial NCT04634253 · COMPLETED

Trial details

NCT number: NCT04634253
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2021-01-04
Primary completion: 2022-01-10
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.